Course overview
Cognitive Decline and Brain Health
In this course, you will explore the current standard of care in Alzheimer's disease and the standard of care clinicians should strive to achieve with patients. Specific goals for treatment and strategies used to reverse and sustain cognitive decline are addressed.
Faculty
Dale Bredesen, MD
Conference Series
AIHM 2020 Annual Conference
Required Lessons
1
Time to Complete
1 hour
non-CME Eligible*
CME Expired
What you will learn
-
Course Summary
-
By the end of this course, learners will be able to:
- Differentiate the current standard of care versus the 21st century standards of care for neurodegenerative diseases.
- Describe strategies used to reverse and sustain cognitive decline in people with Alzheimer's disease.
- Identify goals for treatment and prevention of Alzheimer's disease.
- Recognize the specific reasons for failure of Alzheimer's patients to improve.
Course includes:
Included in this course
Course Faculty
Dale Bredesen, MD
About Dale
Dr. Bredesen earned his MD from Duke University Medical Center and served as Chief Resident in Neurology at the University of California, San Francisco (UCSF), before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen also directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as founding President and CEO.
Dr. Bredesen’s research explores previously uncharted territory in explaining the physical mechanism behind the erosion of memory seen in Alzheimer’s disease, and has opened the door to new approaches to treatment. This work has led to the identification of several new therapeutic processes that are showing remarkable early results. Dr. Bredesen is a prodigious innovator in medicine, with over thirty patents to his name. Notably, he put much of his findings and research into the 2017 New York Times‘ Best-Seller, The End of Alzheimer’s.
Dr. Bredesen’s research explores previously uncharted territory in explaining the physical mechanism behind the erosion of memory seen in Alzheimer’s disease, and has opened the door to new approaches to treatment. This work has led to the identification of several new therapeutic processes that are showing remarkable early results. Dr. Bredesen is a prodigious innovator in medicine, with over thirty patents to his name. Notably, he put much of his findings and research into the 2017 New York Times‘ Best-Seller, The End of Alzheimer’s.
*CME/CEU Credits
The CME for this course has expired, however you will continue to have access to your purchased content.